You are here

Animal models of acute lung injury.

TitleAnimal models of acute lung injury.
Publication TypeJournal Article
Year of Publication2008
AuthorsMatute-Bello, G, Frevert, CW, Martin, TR
JournalAm J Physiol Lung Cell Mol Physiol
Volume295
Issue3
PaginationL379-99
Date Published2008 Sep
ISSN1040-0605
KeywordsAcute Disease, Animals, Bleomycin, Chemokines, Disease Models, Animal, Endothelium, Vascular, Endotoxins, Humans, Hyperoxia, Immunity, Innate, Lung, Lung Injury, Mice, Nitric Oxide, Oleic Acid, Pulmonary Alveoli, Receptors, Chemokine, Respiration, Artificial, Respiratory Distress Syndrome, Adult, Risk Factors, Sepsis, Species Specificity
Abstract

Acute lung injury in humans is characterized histopathologically by neutrophilic alveolitis, injury of the alveolar epithelium and endothelium, hyaline membrane formation, and microvascular thrombi. Different animal models of experimental lung injury have been used to investigate mechanisms of lung injury. Most are based on reproducing in animals known risk factors for ARDS, such as sepsis, lipid embolism secondary to bone fracture, acid aspiration, ischemia-reperfusion of pulmonary or distal vascular beds, and other clinical risks. However, none of these models fully reproduces the features of human lung injury. The goal of this review is to summarize the strengths and weaknesses of existing models of lung injury. We review the specific features of human ARDS that should be modeled in experimental lung injury and then discuss specific characteristics of animal species that may affect the pulmonary host response to noxious stimuli. We emphasize those models of lung injury that are based on reproducing risk factors for human ARDS in animals and discuss the advantages and disadvantages of each model and the extent to which each model reproduces human ARDS. The present review will help guide investigators in the design and interpretation of animal studies of acute lung injury.

DOI10.1152/ajplung.00010.2008
Alternate JournalAm. J. Physiol. Lung Cell Mol. Physiol.
PubMed ID18621912
PubMed Central IDPMC2536793
Grant ListHL-081764 / HL / NHLBI NIH HHS / United States
HL-083044 / HL / NHLBI NIH HHS / United States
R21 RR030249-02 / RR / NCRR NIH HHS / United States